Objectives. West Nile virus (Flavivirus
METHODS
We reviewed peer-reviewed publications and government reports and consulted with key public health officials within Caribbean Basin countries to obtain unpublished data.
RESULTS

West Nile virus detected in 2001
In the State of Florida (United States of America), Blackmore et al. described surveillance findings for WNV in two epidemic foci in 2001-a northern focus and a southern focus (2) . The northern focus was characterized by humid temperate forests typical of the southeastern United States but unlike tropical ecosystems in Latin America. The first evidence for WNV activity here was a dead American Crow (Corvus brachyrhynchos) in June, 2001 . Nine human cases of West Nile neurologic disease (WNND) were reported between July and October. Entomologic investigations near case residences in July detected WNV in three species of Culex (Culex) mosquitoes: Culex quinquefasciatus, C. nigripalpus and C. salinarius (3, 4) . The first two of these species are common further south in the Caribbean Basin.
The southern epidemic focus in Florida was more typical of Caribbean Island ecology and occurred in the Florida Keys. A human case of WNND with onset in July, 2001 , represented the earliest indication of WNV activity there. Two more human cases were reported with onsets in August and September. West Nile virus was isolated from dead corvids (e.g., Fish Crow, Corvus ossifragus) and Streptopelia doves (probably Streptopelia decaocto, Eurasian Collared-Dove, an introduced species that is also abundant in the Bahamas). Entomologic investigations were carried out throughout the Keys during the last quarter of 2001 (5) . Infection rates were highest in Anopheles atropos (3 of (10) . All 17 WNVpositive samples were at least four-fold greater in WNV titer than other flavivirus titers. Three samples were positive for SLEV-neutralizing antibodies, which has been previously isolated in Jamaica (11) . No samples were positive for Ilheus virus, but five additional samples had similar titers for both SLEV and WNV, and these were classified as undetermined flavivirus infections. The 2001 WNV activity in Jamaica and the Cayman Islands was most likely the result of the same introduction mechanism as postulated for extreme southern Florida: southward dispersal of the virus below limits of detection via migrating birds late in 2000.
Operating under the premise that birds would carry WNV along migration routes, efforts were initiated to detect WNV activity on the southern side of (12) . However, these authors cautioned against concluding that WNV had reached southern Mexico. They reasoned that a major range extension should be confirmed by a second detection of infection. Also, no evidence of WNV transmission had been detected at that time in the nearby Yucatán Peninsula (9, 13) . The Chiapas study demonstrated serologic evidence for infections due to uncharacterized flaviviruses which could have resulted in cross-reaction with WNV. Secondary flavivirus infections are notorious for causing elevated heterologous flavivirus titers (14) .
Spread of West Nile virus 2002-2004
In 2002, WNV continued to spread in the Caribbean Basin. Guadeloupe (French West Indies) reported numerous subclinical infections in horses and chickens, determined serologically by neutralization (15) . In July 2002, 10.4% of the healthy horses in four locations were positive and by January 2003, 61.6% had become positive in these locations. The absence of reported neurologic disease in these horses is mysterious. Subsequent surveillance in 2003 and 2004 failed to detect any transmission (16) .
In the Dominican Republic on the Greater Antillean island of Hispaniola, a University of Kansas study team sampled blood and tissues from resident birds captured in November, 2002, for museum collections (17 
DISCUSSION
The failure of efforts to isolate the virus or detect genomic RNA from WNV in Latin America and the Caribbean (with a few exceptions in Mexico) is perplexing and underscores the concern that serologic evidence for WNV activity is at best indirect. Flaviviruses are notorious for their close antigenic relationships and serologic cross-reactivity (10) . In spite of strong serologic evidence from cross-neutralization testing against known flaviviruses from the region, the possibility of misdiagnosis due to cross-reaction with an as yet unrecognized "WN-like" virus still exists. In fact, some of the serologic results classified as due to "undifferentiated flavivirus infection" can best be explained by the existence of such a virus. The recent discovery of two strains of WN-like virus in central Europe lends credence to this concern (32). These two WN-like viruses were both identified serologically as WNV, but genetically they are equidistant from both currently recognized WNV lineages and each other and may represent newly discovered WNV lineages or new WN-like flaviviruses.
Another concern is the strong emphasis placed by several research groups on serologic surveillance of migratory birds (9, 13, 22, 29, 31) . These studies consume large quantities of valuable resources, yet are unlikely to provide significant results. Given the recent intense transmission of WNV during the summers in temperate North America, the capture of WNseropositive avian survivors either during migration or on the wintering grounds is to be expected because many of these birds normally migrate to neotropical winter territories where they probably continue to circulate antibodies derived from a WNV infection acquired on their North American breeding grounds. Some studies claim that seropositive migrants are evidence that birds could carry WNV long distances. Unfortunately, although plausible, this conclusion is not valid for two reasons. First, the possibility that WNseropositive migratory birds were in fact infected locally cannot be disproved. Second, long-distance migration by a healthy, antibody-circulating bird does not indicate that a viremic bird could make the same longdistance flight. More data are needed to support such a hypothesis. However, the observation of infectious WNV at high titers in tissues of convalescent migratory birds (e.g., Killdeer, Charadrius vociferus) more than one week post-infection and the demonstration of oral infection in raptors would suggest that recently infected birds that recover from viremia, migrate, and then fall prey to a raptor may still introduce WNV into new distant ecosystems if the raptor becomes infected and circulates sufficient virus in its blood to infect mosquitoes (33) .
The most pressing concern regarding the reports of WNV in Latin America and the Caribbean is the absence of data on the disease burden in people, horses or birds. Widespread resistance to virulent strains of WNV in Latin American and Caribbean vertebrates (including people) seems highly unlikely. However, the selection of resistant WNV strains is plausible. If migrating birds are indeed the major mechanism for southward dispersal of WNV, then one could imagine a scenario in which birds infected with highly virulent strains become too sick to migrate, while birds infected with avirulent strains make the long flights across seas and deserts successfully, spreading avirulent WNV to new transmission foci along their migratory routes. More research is needed to evaluate this hypothesis, but if proven, this bodes well for the future of WNV epidemics in North America, as the avirulent strain might be reintroduced continually from the south by returning migratory birds. South American arboviruses have in fact been isolated from northward-bound birds during the spring migration in Louisiana (34) . This scenario may also explain the apparent low virulence for SLEV in birds and horses in North and South America. In fact, South American strains of SLEV are also less viremogenic in birds than are North American strains, and less virulent in mice (35) . Whether an avirulent bird and horse strain of WNV will also be less virulent for humans remains to be seen.
Saint Louis encephalitis virus may be responsible for considerable crossreaction to WNV in serologic tests of serum from Latin America. The virus is expected to cross-react in about 5% of primary WNV infections of birds (36) . However, in secondary infections, the proportion of samples that cross-react by PRNT is probably much greater. Secondary flavivirus infections may explain the high rate of flavivirus antibody-positive serum samples in the Caribbean Basin countries that cannot be assigned to a specific infection (because of the presence of similar titers for multiple flaviviruses). Although rarely associated with disease in Latin America, SLEV infections are commonly reported. For example, in Chiapas, Mexico, 20 (10%) of 196 domestic animals (including three of five horses) were diagnosed as positive for SLEV-neutralizing antibodies by PRNT (12) . The known range of distribution for SLEV was expanded through the efforts to detect WNV in the Caribbean Basin. For example, two SLE-seropositive birds reported in Puerto Rico provide the first evidence of SLEV activity from that Caribbean location (9, 29) .
CONCLUSION AND RECOMMENDATIONS
Although WNV has yet to present a serious disease threat in Latin America and the Caribbean Basin, an outbreak may be pending. The first major outbreak (with >100 human cases of WNND) in the United States was delayed until 2002, three years after initial detection of the virus in 1999. Public health and veterinary authorities in Latin America and the Caribbean should remain vigilant for unusual clusters of severe disease cases. Dead birds (especially corvids) have been particularly useful for the early detection of WNV activity in North America (37) . Corvids are less abundant in Latin America, and thus avian mortality may be less useful as a surveillance technique in this region (38) . In countries where WNV has already been detected, surveillance efforts should be expanded. Surveillance guidelines for Latin American and Caribbean Basin countries are available (28, 39, 40) .
Objetivos. El virus del Nilo occidental (VNO, familia Flaviviridae, género Flavivirus) se ha propagado rápidamente por toda la cuenca del Caribe desde que se detectó por primera vez en 2001. En este informe se resumen nuestros conocimientos actuales acerca de la transmisión del VNO en zonas tropicales del continente americano. Métodos. Revisamos todo lo que se ha publicado sobre el tema y consultamos a autoridades de salud clave para obtener datos inéditos. Resultados. Las infecciones por el virus del Nilo occidental aparecieron por primera vez en seres humanos residentes de las Islas Caimán y de los Cayos de la Florida en 2001, y en pájaros de aspecto sano de los cuales se obtuvieron muestras a principios de 2002. En 2002 se encontraron pruebas serológicas de infección por el VNO en caballos, pollos y aves de corral no estabuladas oriundas de Guadalupe, la República Dominicana y la parte oriental de México. En 2003, el VNO se diseminó dentro de México y por la parte norte de Centroamérica y se encontraron pruebas serológicas en las Bahamas, Puerto Rico y Cuba. En 2004, las primeras pruebas serológicas de actividad vírica en ecosistemas sudamericanos se detectaron en septiembre y octubre en Colombia y Trinidad, donde se observaron anticuerpos neutralizantes contra el VNO en animales domésticos. Conclusiones. Estos informes esporádicos de enfermedad equina, humana y aviar en América Latina y el Caribe son desconcertantes. Es necesario aislar las cepas para determinar si la atenuación del virus u otro factor explica la carga de enfermedad reducida en ecosistemas tropicales.
Virus del Nilo occidental, América Latina, región del Caribe, arbovirus, vigilancia de la población, flavivirus.
RESUMEN
La actividad del virus del Nilo occidental en América Latina y el Caribe
